²é¿´: 2314  |  »Ø¸´: 11
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

rhett82

½ð³æ (СÓÐÃûÆø)

ÆÐÌá±¾ÎÞÊ÷,Ã÷¾µÒà·Ç̨,±¾À´ ...

[½»Á÷] ¡¾Ô­´´¡¿×Ô¼º×ܽáµÄһЩ¶«Î÷£¬Ï£Íû¶Ô´ó¼ÒÓÐËù°ïÖú£¡

¸üÒÂÊÒ   Changing Room
Ò»¸ü     First Changing Room
ÊÖÏûÊÒ   Hands Disinfection Room
ÆøÕ¢ÊÒ   Airlock Room
½à¾ßÊÒ   Cleaning Tools Room
ÇåÏ´ÊÒ   Cleaning Room
Ä£¾ßÊÒ   Dies Room
ÄÚ°ü×°ÊÒ Immediate Package Room
°²È«ÃÅ   Emergency Door
Íâ°üÇåÊÒ Outer Package Removing Room
´æÁÏ¼ä   Storage Room of Raw Materials
·ÛËéÊÒ   Pulverizing Room
±¸ÁÏÊÒ   Materials Preparing Room
Ó²½ºÊÒ   Hard Capsules Filling Room
Èí½ºÊÒ   Soft Capsules Room
ÖÆÁ£¸ÉÔïÊÒ   Granulating and Drying Room
×Ü»ì¼ä   Blending Room
ÖмäÕ¾   Intermediate Station
ѹƬÊÒ   Tablets Room Compression Room
°üÒÂÊÒ   Coating Room
Å佬¼ä   Coating Mixture Preparing Room
ÂÁËܰü×°¼ä   Packing Room
´«µÝ´°   Transferring Window
Íâ°ü×°ÊÒ Outer Packing Room
ÕôÁóË®ÊÒ Water Purifying Room
ÖʼìÊÒ   Quality Control Room
ŨÅäÊÒ   Concentrated Solution Room
Ï¡ÅäÊÒ   Diluted Solution Room

BATCH PRODUCTION£ºÅúÁ¿Éú²ú£»·ÖÅúÉú²ú
BATCH PRODUCTION RECORDS£ºÉú²úÅúºÅ¼Ç¼
POST-OR PRE- MARKET SURVEILLANCE£ºÏúÊÛǰ»òÏúÊÛºó¼à¶½
INFORMED CONSENT£ºÖªÇéͬÒ⣨»¼Õß¶ÔÖÎÁÆ»òÊÜÊÔÕß¶ÔÒ½ÁÆÊÔÑéÁ˽âºó±íʾͬÒâ½ÓÊÜÖÎ
ÁÆ»òÊÔÑ飩
PRESCRIPTION DRUG£º´¦·½Ò©
OTC DRUG£¨OVER¡ªTHE¡ªCOUNTER DRUG£©£º·Ç´¦·½Ò©
U£®S£®PUBLIC HEALTH SERVICE£ºÃÀ¹úÎÀÉú¸£Àû²¿
Ò©Æ·ÖÆ±¸ preparation of drug products
Õë¶Ô     pertain to
ÈËÓÃÉúÎïÖÆÆ·   biological products for human use
²¹³ä      supplement
´úÌæÌõÀý    supersede the requlation
ÌáÒéÃâ³ý    proposed exemption
Ò»°ãÏúÊÛºÍÏû·Ñ   ordinarily marketed and consumed
ÃÀµÂ£¬Óŵ㣬ЧÁ¦  virtue
Áª°î×¢²á±í   FR/federal register
ÈËÓÃÎïÆ·  human foods
ÓÃÓÚ¼ø±ð£¬²â¶¨  shall be applied in determining
Éú²ú£¬¼Ó¹¤£¬°ü×°£¬Öü´æ  manufacture,process,pack,hold,
Ö°ÔðºÍȨÁ¦    responsibility and authority
Åú×¼ºÍ¾ÜÊÕ   approve or reject/withhold
¸´²éÉú²ú¼Ç¼    review production records
¶ÔqcÀ´Ëµ¿ÉÒÔ»ñµÃµÄ    shall be available to QC
Êʵ±µÄ      adequate
Ч¼ÛºÍº¬Á¿   strength
Ìṩ֤Ã÷Îļþ  shall be documented
·ûºÏ   conform to
ÖÆ¶©ÍêÉÆ   sound
ÿװ»õÁ¿  each shipment
±äÖʵĠ   is subject to deterioration
accommodation  (³µ£¬´¬£¬·É»úµÈµÄ)Ô¤¶¨ÆÌλ
ÅúºÅ  batch
Óк¦Î¢ÉúÎï  objectionable microorganism
ÁªºÏÅúºÅ   the number of units
׼ȷÐÔ£¬ÁéÃôÐÔ£¬ÌØÒìÐÔ£¬Öظ´ÐÔ
accuracy, sensitivity, specificity, and reproducibility
ÌØÕ÷£¬ÊôÐÔ attribute
ÅäÎé    reconstitution
Éè¼Æ   project
Ë³ÊÆÖÎÁÆÒ©Æ·   homeopathic drug products
¿ÉÅäÎéÐÔ    compatibility
±êÃ÷   purporting to
Ó¦³ÉÎIJ¢×ñÑ­    shall be in writing and shall be followed.
¿É¼ì³öˮƽ   detectable levels
ͨ¹ý²Î¿¼ÎÄÏ×¾ßÌ廯  incorporated by reference
¸±×÷Óà adeverse/side effect
ÀàÐÍ  type
»ì·Å   mixups
Ç©ÊÕ  receipt
´¦Àí  disposition
ÕýѹϹýÂË  be filtered under positive pressure  
²ãÁ÷»ò·Ç²ãÁ÷    laminar or nonlaminar;
ÎÞ¾ú»·¾³    aseptic conditions
ÕÕÃ÷   lighting
ͨ·ç¡¢¿ÕÆø¹ýÂË¡¢¿ÕÆø¼ÓÈÈÓëÀäÈ´   Ventilation, air filtration, air heating and cooling.
¿ÕÆøÊäËÍϵͳ   Air-handling systems
¸½½ü½¨ÖþÎï    immediate premises
רÓÃë½í  single-service towels
½øÁÏ   Charge-in
±êʾÁ¿»ò¹æ¶¨Á¿    labeled or established amount
ʵ¼Ê²úÁ¿   Actual yields
ÀíÂÛ²úÁ¿   theoretical yields
Éú²úÖÜÆÚ   the production of a batch of a drug product
Ò©Æ·µÄÒ»ÖÂÐÔºÍÍêÕûÐÔ    uniformity and integrity of drug products
±À½âʱ¼ä  Disintegration time
ÈÜÒºµÄ³ÎÃ÷¶È¡¢ÈܽâÍêÈ«ÐÔ¼°pHÖµ   Clarity, completeness, or pH of solutions
Îȶ¨ÐÔÆÀ¹À   variability estimates
װж  handling
NIH£¨NATIONAL INSTITUTE OF HEALTH£©£º£¨ÃÀ¹ú£©È«¹úÎÀÉúÑо¿Ëù
CLINICAL TRIAL£ºÁÙ´²ÊÔÑé
ANIMAL TRIAL£º¶¯ÎïÊÔÑé
ACCELERATED APPROVAL£º¼ÓËÙÅú×¼
FDA£¨FOOD AND DRUG ADMINISTRATION£©£º£¨ÃÀ¹ú£©Ê³Æ·Ò©Æ·¹ÜÀí¾Ö
IND£¨INVESTIGATIONAL NEW DRUG£©£ºÁÙ´²Ñо¿ÉêÇ루ָÉ걨½×¶Î£¬Ïà¶Ô
ÓÚNDA¶øÑÔ£©£»Ñо¿ÖеÄÐÂÒ©£¨Ö¸ÐÂÒ©¿ª·¢½×¶Î£¬Ïà¶ÔÓÚÐÂÒ©¶øÑÔ£¬¼´ÁÙ´²Ç°Ñо¿½áÊø£©
NDA£¨NEW DRUG APPLICATION£©£ºÐÂÒ©ÉêÇë
ANDA£¨ABBREVIATED NEW DRUG APPLICATION£©£º¼ò»¯ÐÂÒ©ÉêÇë
EPËߣ¨EXPORT APPLICATION £©£º³ö¿ÚÒ©ÉêÇ루ÉêÇë³ö¿Ú²»±»Åú×¼ÔÚÃÀ¹ú
ÏúÊÛµÄÒ©Æ·£©
TREATMENT IND£ºÑо¿ÖеÄÐÂÒ©ÓÃÓÚÖÎÁÆ
ABBREVIATED£¨NEW£©DRUG£º¼ò»¯ÉêÇëµÄÐÂÒ©
DMF£¨DRUG MASTER FILE£©£ºÒ©ÎïÖ÷Îļþ£¨³ÖÓÐÕßΪ½÷É÷Æð¼û¶ø×¼±¸µÄ±£
ÃÜ×ÊÁÏ£¬¿ÉÒÔ°üÀ¨Ò»¸ö»ò¶à¸öÈËÓÃÒ©ÎïÔÚÖÆ±¸¡¢¼Ó¹¤¡¢ °ü×°ºÍÖü´æ¹ý³ÌÖÐËù¼°µÄÉ豸¡¢Éú²ú¹ý³Ì»òÎïÆ·¡£Ö»ÓÐÔÚDMF³ÖÓÐÕß»òÊÚȨ´ú±íÒÔÊÚȨÊéµÄÐÎʽÊÚȨ¸øFDA£¬FDAÔÚÉó²éIND¡¢NDA¡¢ANDAʱ²ÅÄܲο¼ÆäÄÚÈÝ£©
HOLDER£ºDMF³ÖÓÐÕß
CFR£¨CODE OF FEDERAL REGULATION£©£º£¨ÃÀ¹ú£©Áª°î·¨¹æ
PANEL£º×¨¼ÒС×é
BATCH PRODUCTION£ºÅúÁ¿Éú²ú£»·ÖÅúÉú²ú
BATCH PRODUCTION RECORDS£ºÉú²úÅúºÅ¼Ç¼
POST-OR PRE- MARKET SURVEILLANCE£ºÏúÊÛǰ»òÏúÊÛºó¼à¶½
INFORMED CONSENT £ºÖªÇéͬÒ⣨»¼Õß¶ÔÖÎÁÆ»òÊÜÊÔÕß¶ÔÒ½ÁÆÊÔÑéÁ˽âºó±íʾͬÒâ½ÓÊÜÖÎÁÆ»òÊÔÑ飩
PRESCRIPTION DRUG£º´¦·½Ò©
OTC DRUG£¨OVER¡ªTHE¡ªCOUNTER DRUG£©£º·Ç´¦·½Ò©
U£®S£®PUBLIC HEALTH SERVICE£ºÃÀ¹úÎÀÉú¸£Àû²¿
NIH£¨NATIONAL INSTITUTE OF HEALTH£©£º£¨ÃÀ¹ú£©È«¹úÎÀÉúÑо¿Ëù
CLINICAL TRIAL£ºÁÙ´²ÊÔÑé
ANIMAL TRIAL£º¶¯ÎïÊÔÑé
ACCELERATED APPROVAL£º¼ÓËÙÅú×¼

Acceptance Criteria ¨C ½ÓÊÕ±ê×¼
½ÓÊÕ²âÊÔ½á¹ûµÄÊý×ÖÏÞ¶È¡¢·¶Î§»òÆäËüºÏÊʵÄÁ¿¶È±ê×¼¡£

Active Pharmaceutical Ingredient (API)(or Drug Substance) ¨C »îÐÔÒ©ÓÃ³É·Ö (Ô­ÁÏÒ©)
Ö¼ÔÚÓÃÓÚÒ©Æ·ÖÆÔìÖеÄÈκÎÒ»ÖÖÎïÖÊ»òÎïÖʵĻìºÏÎ¶øÇÒÔÚÓÃÓÚÖÆÒ©Ê±£¬³ÉΪҩƷµÄÒ»ÖÖ»îÐԳɷ֡£´ËÖÖÎïÖÊÔÚ¼²²¡µÄÕï¶Ï£¬ÖÎÁÆ£¬Ö¢×´»º½â£¬´¦Àí»ò¼²²¡µÄÔ¤·ÀÖÐÓÐÒ©Àí»îÐÔ»òÆäËüÖ±½Ó×÷Ó㬻òÕßÄÜÓ°Ïì»úÌåµÄ¹¦Äܺͽṹ¡£

API Starting Material ¨C Ô­ÁÏÒ©µÄÆðʼÎïÁÏ
ÓÃÔÚÔ­ÁÏÒ©Éú²úÖеģ¬ÒÔÖ÷Òª½á¹¹µ¥Ôª±»²¢Èë¸ÃÔ­ÁÏÒ©µÄÔ­ÁÏ¡¢ÖмäÌå»òÔ­ÁÏÒ©¡£Ô­ÁÏÒ© µÄÆðʼÎïÁÏ¿ÉÄÜÊÇÔÚÊг¡ÉÏÓÐÊÛ£¬Äܹ»¸ù¾ÝºÏͬ»òÉÌҵЭÒé´ÓÒ»¸ö»ò¶à¸ö¹©Ó¦ÉÌ´¦¹ºµÃ£¬»òÕß×Ô¼ºÉú²ú¡£Ô­ÁÏÒ©µÄÆðʼÎïÁÏͨ³£ÓÐÌØ¶¨µÄ»¯Ñ§ÌØÐԺͽṹ¡£

Batch (or Lot) ¨C Åú
ÓÉÒ»¸ö»òһϵÁй¤ÒÕ¹ý³ÌÉú²úµÄÒ»¶¨ÊýÁ¿µÄÎïÁÏ£¬Òò´ËÔڹ涨µÄÏÞ¶ÈÄÚÊǾùÒ»µÄ¡£ÔÚÁ¬ÐøÉú²úÖУ¬Ò»Åú¿ÉÄܶÔÓ¦ÓÚÓëÉú²úµÄÄ³Ò»ÌØ¶¨²¿·Ö¡£ÆäÅúÁ¿¿É¹æ¶¨ÎªÒ»¸ö¹Ì¶¨ÊýÁ¿£¬»òÔڹ̶¨Ê±¼ä¼ä¸ôÄÚÉú²úµÄÊýÁ¿¡£

Batch Number (or Lot Number) ¨C ÅúºÅ
ÓÃÓÚ±êʶһÅúµÄÒ»¸öÊý×Ö¡¢×ÖĸºÍ/»ò·ûºÅµÄΨһ×éºÏ£¬´ÓÖпÉÈ·¶¨Éú²úºÍÏúÊÛµÄÀúÊ·¡£

Bioburden ¨C ÉúÎï¸ºÔØ
¿ÉÄÜ´æÔÚÓÚÔ­ÁÏ¡¢Ô­ÁÏÒ©µÄÆðʼÎïÁÏ¡¢ÖмäÌå»òÔ­ÁÏÒ©ÖеÄ΢ÉúÎïµÄˮƽºÍÖÖÀà(ÀýÈ磬Ö²¡µÄ»ò²»Ö²¡µÄ)¡£ÉúÎï¸ºÔØ²»Ó¦µ±µ±×÷ÎÛȾ£¬³ý·Çº¬Á¿³¬±ê£¬»òÕß²âµÃÖ²¡ÉúÎï¡£

Calibration ¨C УÑé
Ö¤Ã÷ij¸öÒÇÆ÷»ò×°ÖÃÔÚÒ»Êʵ±µÄÁ¿³Ì·¶Î§ÄÚËù²âµÃµÄ½á¹ûÓëÒ»²ÎÕÕÎ»ò¿É×·Ëݵıê×¼Ïà±ÈÔڹ涨ÏÞ¶ÈÄÚ¡£

Computer System ¨C ¼ÆËã»úϵͳ
Éè¼Æ°²×°ÓÃÓÚÖ´ÐÐijһÏî»òÒ»×鹦ÄܵÄÒ»×éÓ²¼þÔª¼þºÍ¹ØÁªµÄÈí¼þ¡£

Computerized System ¨C ¼ÆËã»ú»¯ÏµÍ³
Óë¼ÆËã»úϵͳÕûºÏµÄÒ»¸ö¹¤ÒÕ»ò²Ù×÷¡£

Contamination ¨C ÎÛȾ
ÔÚÉú²ú¡¢È¡Ñù¡¢°ü×°»òÖØÐ°ü×°¡¢Öü´æ»òÔËÊä¹ý³ÌÖУ¬¾ß»¯Ñ§»ò΢ÉúÎïÐÔÖʵÄÔÓÖÊ»òÍâÀ´ÎïÖʽøÈë»òմȾԭÁÏ¡¢ÖмäÌå»òÔ­ÁÏÒ©¡£

Contract Manufacturer ¨C ЭÒéÖÆÔìÉÌ
´ú±íÔ­ÖÆÔìÉ̽øÐв¿·ÖÖÆÔìµÄÖÆÔìÉÌ¡£

Critical ¨C ¾ö¶¨ÐÔµÄ
ÓÃÀ´ÃèÊöΪÁËÈ·±£Ô­ÁÏÒ©·ûºÏ¹æ¸ñ±ê×¼£¬±ØÐë¿ØÖÆÔÚÔ¤¶¨·¶Î§ÄڵŤÒÕ²½Öè¡¢¹¤ÒÕÌõ¼þ¡¢²âÊÔÒªÇó»òÆäËüÓйزÎÊý»òÏîÄ¿¡£

Cross-Contamination ¨C ½»²æÎÛȾ
Ò»ÖÖÎïÁÏ»ò²úÆ·¶ÔÁíÒ»ÖÖÎïÁÏ»ò²úÆ·µÄÎÛȾ¡£

Deviation ¨C Æ«²î
¶ÔÅú×¼µÄÖ¸Áî»ò¹æ¶¨µÄ±ê×¼µÄÆ«Àë¡£

Drug (Medicinal) Product ¨C Ò©Æ·
¾­×îºó°ü×°×¼±¸ÏúÊÛµÄÖÆ¼Á(²Î¼ûQ1A)¡£

Drug Substance ¨C Ò©Îï
¼ûÔ­ÁÏÒ©

Expiry Date (or Expiration Date) ¨C ÓÐЧÆÚ
Ô­ÁÏÒ©ÈÝÆ÷/±êÇ©ÉÏ×¢Ã÷µÄÈÕÆÚ£¬Ôڴ˹涨ʱ¼äÄÚ£¬¸ÃÔ­ÁÏÒ©Ôڹ涨Ìõ¼þÏÂÖü´æÊ±£¬ÈÔ·ûºÏ¹æ¸ñ±ê×¼£¬³¬¹ýÕâÒ»ÆÚÏÞÔò²»Ó¦µ±Ê¹Óá£

Impurity ¨C ÔÓÖÊ
´æÔÚÓÚÖмäÌå»òÔ­ÁÏÒ©ÖУ¬Èκβ»Ï£ÍûµÃµ½µÄ³É·Ö¡£

Impurity Profile ¨C ÔÓÖʸſö
¶Ô´æÔÚÓÚÒ»ÖÖÔ­ÁÏÒ©ÖеÄÒÑÖªºÍδ֪ÔÓÖʵÄÃèÊö¡£

In-Process Control (or Process Control) ¨C ÖÐ¼ä¿ØÖÆ
Éú²ú¹ý³ÌÖÐΪ¼à²â£¬ÔÚ±ØÒªÊ±µ÷½Ú¹¤ÒÕºÍ/»ò±£Ö¤ÖмäÌå»òÔ­ÁÏÒ©·ûºÏÆä¹æ¸ñ¶ø½øÐеļì²é¡£

Intermediate ¨C ÖмäÌå
Ô­ÁÏÒ©¹¤ÒÕ²½ÖèÖвúÉúµÄ¡¢±ØÐë¾­¹ý½øÒ»²½·Ö×ӱ仯»ò¾«ÖƲÅÄܳÉΪԭÁÏÒ©µÄÒ»ÖÖÎïÁÏ¡£ÖмäÌå¿ÉÒÔ·ÖÀë»ò²»·ÖÀë¡£(×¢£º±¾Ö¸ÄÏֻɿ¼°¸Ã¹«Ë¾¶¨ÒåΪԭÁÏÒ©Éú²úÆðʼµãÒÔºóÉú²úµÄÖмäÌå¡£)

Lot ¨C Åú
¼ûÅú(Batch)¡£

Lot Number ¨C ÅúºÅ
¼ûÅúºÅ(Batch Number)

Manufacture ¨C ÖÆÔì
ÎïÁϵĽÓÊÕ¡¢Ô­ÁÏÒ©µÄÉú²ú¡¢°ü×°¡¢ÖØÐ°ü×°¡¢ÌùÇ©¡¢ÖØÐÂÌùÇ©¡¢ÖÊÁ¿¿ØÖÆ¡¢·ÅÐС¢Öü´æºÍ·Ö·¢ÒÔ¼°Ïà¹Ø¿ØÖƵÄËùÓвÙ×÷¡£

Material ¨C ÎïÁÏ
Ô­ÁÏ(ÆðʼÎïÁÏ£¬ÊÔ¼Á£¬ÈܼÁ)£¬¹¤ÒÕ¸¨ÖúÓÃÆ·£¬ÖмäÌ壬ԭÁÏÒ©£¬ ºÍ°ü×°¼°ÌùÇ©²ÄÁϵÄͳ³Æ¡£

Mother Liquor ¨C ĸҺ
½á¾§»ò·ÖÀëºóʣϵIJÐÁôÒº¡£Ä¸Òº¿ÉÄܺ¬ÓÐδ·´Ó¦µÄÎïÁÏ¡¢ÖмäÌå¡¢²»Í¬¼¶±ðµÄÔ­ÁÏÒ©ºÍ/»òÔÓÖÊ¡£Ëü¿ÉÓÃÓÚ½øÒ»²½¼Ó¹¤¡£

Packaging Material ¨C °ü×°²ÄÁÏ
ÔÚ´¢Ô˹ý³ÌÖб£»¤ÖмäÌå»òÔ­ÁÏÒ©µÄÈκÎÎïÁÏ¡£

Procedure ¨C ³ÌÐò
¶ÔÒª½øÐеIJÙ×÷¡¢Òª²ÉÈ¡µÄÔ¤·À´ëÊ©ÒÔ¼°ÓëÔ­ÁÏÒ©»òÖмäÌåÉú²úÖ±½Ó»ò¼ä½ÓÏà¹ØµÄ·½·¨µÄÃèÊöÎļþ¡£

Process Aids ¨C ¹¤ÒÕ¸¨ÁÏ
³ýÈܼÁÍ⣬ÔÚÔ­ÁÏÒ©»òÖмäÌåÉú²úÖÐÆð¸¨Öú×÷Óᢱ¾Éí²»²ÎÓ뻯ѧ»òÉúÎïѧ·´Ó¦µÄÎïÁÏ(ÀýÈ磬ÖúÂ˼Á¡¢»îÐÔÌ¿)¡£

Process Control ¨C ¹¤ÒÕ¿ØÖÆ
¼ûÖÐ¼ä¿ØÖÆ

Production ¨C Éú²ú
ÔÚÔ­ÁÏÒ©ÖÆ±¸¹ý³ÌÖУ¬´Ó½ÓÊÕÔ­ÁÏ£¬µ½¹¤ÒÕ¼Ó¹¤ºÍÔ­ÁÏÒ©°ü×°ËùÉæ¼°µÄËùÓвÙ×÷¡£

Qualification ¨C È·ÈÏ
Ö¤Ã÷É豸»ò¸¨Öúϵͳ£¬°²×°ÕýÈ·¡¢¹¤×÷Õý³£¡¢È·Êµ²úÉúÔ¤ÆÚµÄ½á¹û£¬²¢ÒÔÎļþ×ôÖ¤µÄÐÐΪ¡£È·ÈÏÊÇÑéÖ¤µÄÒ»²¿·Ö£¬µ«µ¥¶ÀµÄÈ·Èϲ½Öè²»¹¹³É¹¤ÒÕÑéÖ¤¡£

Quality Assurance (QA) ¨C ÖÊÁ¿±£Ö¤
ÒÔÈ·±£ËùÓÐÔ­ÁÏÒ©´ïµ½ÆäÓ¦ÓÃËùÒªÇóµÄÖÊÁ¿£¬²¢Î¬³ÖÖÊÁ¿ÌåϵΪĿµÄµÄÈ«²¿×éÖ¯°²ÅŵÄ×ܺ͡£

Quality Control ¨C ÖÊÁ¿¿ØÖÆ
ÊÇ·ñ·ûºÏÖÊÁ¿¹æ¸ñµÄ¼ì²é»ò²âÊÔ¡£

Quality Unit(s) ¨C ÖÊÁ¿²¿ÃÅ
¶ÀÁ¢ÓÚÉú²ú²¿ÃŵÄÂÄÐÐÖÊÁ¿±£Ö¤ºÍÖÊÁ¿¿ØÖÆÖ°ÔðµÄ×éÖ¯»ú¹¹¡£°´ÕÕ×éÖ¯»ú¹¹µÄ´óСºÍ½á¹¹£¬¿ÉÒÔÊǵ¥¶ÀµÄQA ºÍQC²¿ÃÅ£¬»ò¸öÈË£¬»òС×é¡£

Quarantine ¨C ´ýÑé
ÔÚʵÎïÉÏ»òÒÔÆäËüÓÐЧ·½Ê½½«ÎïÁϸôÀ룬µÈ´ý¶ÔÆäËæºóµÄÅú×¼»ò¾ÜÊÕ×ö³ö¾ö¶¨µÄ״̬¡£

Raw Material ¨C Ô­ÁÏ
ÓÃÀ´±íʾÖмäÌå»òÔ­ÁÏÒ©µÄÉú²úÖÐÒªÓÃµÄÆðʼÎïÁÏ¡¢ÊÔ¼ÁºÍÈܼÁµÄͨÓÃרҵÃû´Ê¡£

Reference Standard, Primary ¨C »ù×¼²Î¿¼±ê׼Ʒ
¾­¹ã·º·ÖÎö²âÊÔ±íÃ÷¾ßÓпÉÐŵĸߴ¿¶ÈµÄÎïÖÊ¡£ÕâÀà±ê׼Ʒ¿ÉÒÔ£º1)À´Ô´ÓÚ·¨¶¨µÄ»ú¹¹£¬2)¶ÀÁ¢ºÏ³É£¬3)À´×ÔÓڸߴ¿¶ÈµÄÏÖÓÐÉú²úÎïÁÏ£¬»ò4)ÓýøÒ»²½¾«ÖÆÏÖÓÐÉú²úÎïÁϵķ½·¨À´ÖƱ¸¡£

Reference Standard, Secondary ¨C ¶þ¼¶²Î¿¼±ê׼Ʒ
Óë»ù×¼²Î¿¼±ê׼Ʒ±È½ÏÏÔʾ¾ßÓй涨µÄÖÊÁ¿ºÍ´¿¶È£¬²¢ÓÃ×÷ÈÕ³£ÊµÑéÊÒ·ÖÎöµÄ²Î¿¼±ê׼Ʒ¡£

Reprocessing ¨C ·µ¹¤
½«²»·ûºÏ±ê×¼»ò¹æ¸ñµÄÒ»¸öÖмäÌå»òÔ­ÁÏÒ©·µ»Ø¹¤ÒÕ¹ý³Ì£¬Öظ´¹æ¶¨µÄÉú²ú¹¤ÒÕÖеÄijһ½á¾§²½Öè»òÆäËüºÏÊʵĻ¯Ñ§»òÎïÀí´¦Àí²½Öè (Èç ÕôÁ󣬹ýÂË£¬²ãÎö£¬Ä¥·Û)£¬ÕâÖÖ×ö·¨Í¨³£ÊÇ¿ÉÒÔ½ÓÊܵġ£ÔÚÖÐ¼ä¿ØÖÆµÄ²âÊÔ±íÃ÷Ò»¹¤ÒÕ²½ÖèûÓÐÍê³É£¬´Ó¶ø¼ÌÐø¸Ã²½Ö裬ÊÇÕý³£¹¤ÒÕµÄÒ»²¿·Ö£¬¶ø²»ÊÇ·µ¹¤¡£

Retest Date ¨C ¸´ÑéÈÕÆÚ
ÎïÁÏÓ¦µ±ÖØÐ¼ìÑéÒÔÈ·±£ÆäÈÔ¿ÉʹÓõÄÈÕÆÚ¡£

Reworking ¨C ÖØÐ¼ӹ¤
½«²»·ûºÏ¹æ¸ñ±ê×¼µÄÖмäÌå»òÔ­ÁÏÒ©Óò»Í¬Óڹ涨Éú²ú¹¤ÒÕµÄÒ»¸ö»ò¼¸¸ö²½Öè½øÐд¦Àí£¬ÒԵõ½ÖÊÁ¿¿É½ÓÊܵÄÖмäÌå»òÔ­ÁÏÒ©(È磺Óò»Í¬ÈܼÁµÄÔٽᾧ)¡£

Signature (Signed) ¨C Ç©Ãû
×ö¹ýÄ³Ò»ÌØ¶¨Ðж¯»òÉóºËµÄ¸öÈ˵ÄÒ»ÖּǼ¡£´ËÀà¼Ç¼¿ÉÒÔÊÇÊ××ÖĸËõд¡¢ÊÖдȫÃû¡¢¸öÈËÓ¡Õ»ò¾­Ö¤ÊµµÄ¿É¿¿µÄµç×ÓÇ©Ãû¡£

Solvent ¨C ÈܼÁ
ÖмäÌå»òÔ­ÁÏÒ©ÖÐÓÃ×÷ÖÆ±¸ÈÜÒº»òÐü¸¡ÒºµÄÔØÌåµÄÎÞ»ú»òÓлúÒºÌå¡£

Specification ¨C ¹æ¸ñ
һϵÁеIJâÊÔÏîÄ¿¡¢ÓйصķÖÎö³ÌÐòºÍÊʵ±µÄÈϿɱê×¼£¬´Ë±ê×¼¿ÉÒÔÊÇÊýÖµÏÞ¶È¡¢·¶Î§»òËùÊö²âÊÔÏîÄ¿µÄÆäËü±ê×¼¡£Ëü¹æ¶¨Ò»Ì×±ê×¼£¬ÎïÁÏÓ¦µ±·ûºÏ¸Ã±ê×¼£¬²Å±»ÈÏΪ¿ÉÒÔÓÃ×÷ÆäÔ¤ÆÚµÄÓÃ;¡£ ¡°·ûºÏ¹æ¸ñ¡±±íʾÎïÁϰ´ËùÁеķÖÎö³ÌÐò²âÊÔʱ£¬»á·ûºÏËùÁеĽÓÊܱê×¼¡£

Validation ¨C ÑéÖ¤
ÎªÄ³Ò»ÌØ¶¨µÄ¹¤ÒÕ¡¢·½·¨»òϵͳÄܹ»³ÖÐøµØ²úÉú·ûºÏ¼È¶¨½ÓÊܱê×¼µÄ½á¹ûÌṩ³ä·Ö±£Ö¤µÄÎļþ³ÌÐò¡£

Validation Protocol ¨C ÑéÖ¤·½°¸
˵Ã÷ÈçºÎ½øÐÐÑéÖ¤ºÍ¹æ¶¨½ÓÊܱê×¼µÄÊéÃæ¼Æ»®¡£ÀýÈ磬Éú²ú¹¤ÒÕÑéÖ¤·½°¸È·¶¨¹¤ÒÕÉ豸¡¢¹Ø¼üÐÔ¹¤ÒÕ²ÎÊý/²Ù×÷·¶Î§¡¢²úÆ·ÌØÐÔ¡¢È¡Ñù¡¢ÊÕ¼¯µÄ²âÊÔÊý¾Ý¡¢ÑéÖ¤µÄ´ÎÊý£¬ÒÔ¼°¿É½ÓÊܵIJâÊÔ½á¹û¡£

Yield, Expected ¨C Ô¤ÆÚ²úÁ¿
ÔÚÒÔǰʵÑéÊÒ¡¢ÖÐÊÔ¹æÄ£»òÉú²úÊý¾ÝµÄ»ù´¡ÉÏ£¬Ô¤¼ÆÈκÎÊʵ±µÄÉú²ú½×¶ÎµÄÎïÁϵÄÁ¿»òÀíÂÛ²úÁ¿µÄ°Ù·Ö±È¡£

Yield, Theoretical ¨C ÀíÂÛ²úÁ¿
¸ù¾ÝͶÁÏÁ¿£¬²»¼ÆÈκÎʵ¼ÊÉú²úÖеÄËðʧ»ò¹ýʧ£¬¼ÆËãÈκÎÊʵ±µÄÉú²ú½×¶ÎÉú²úµÄÁ¿¡£

[ Last edited by laizuliang on 2007-9-21 at 07:53 ]
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

ÖÆÒ© ÖÊÁ¿ÏµÍ³

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÆÐÌá±¾ÎÞÊ÷,Ã÷¾µÒà·Ç̨,±¾À´ÎÞÒ»Îï,ºÎ´¦Èdz¾°££®
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yqfeng2001

ľ³æ (ÕýʽдÊÖ)

0.5

ºÃ¶à°¡
xie xie la
10Â¥2007-03-11 10:41:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 12 ¸ö»Ø´ð

gongjw123

ÍÚ,ÕæÊÇÓÐÐÄÈË
±£´æÁË,лÁË!
9Â¥2007-03-10 21:33:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

tcm2000

ľ³æ (ÖøÃûдÊÖ)

ÊÕ²Ø
ѧϰ
лл£¡£¡
12Â¥2007-06-06 11:08:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 280Çóµ÷¼Á +4 ¹¾ààÏþÏþ 2026-03-18 4/200 2026-03-18 10:27 by zeng1010
[¿¼ÑÐ] 085601ר˶£¬×Ü·Ö342Çóµ÷¼Á£¬µØÇø²»ÏÞ +4 share_joy 2026-03-16 4/200 2026-03-17 21:32 by hmn_wj
[¿¼ÑÐ] 08¹¤¿Æ 320×Ü·Ö Çóµ÷¼Á +4 À滨çóÍí·ç 2026-03-17 4/200 2026-03-17 13:38 by houyaoxu
[¿¼²©] 26É격 +4 °ËÑ®ËÙÀÀ 2026-03-16 4/200 2026-03-17 13:00 by ÇáËɲ»ÉÙËæ
[¿¼ÑÐ] 275Çóµ÷¼Á +4 Ì«Ñô»¨ÌìÌ쿪ÐÄ 2026-03-16 4/200 2026-03-17 10:53 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] 302Çóµ÷¼Á +4 С¼Öͬѧ123 2026-03-15 8/400 2026-03-17 10:33 by С¼Öͬѧ123
[¿¼ÑÐ] ¿¼Ñе÷¼Á +3 ä¿ya_~ 2026-03-17 5/250 2026-03-17 09:25 by Winj1e
[»ù½ðÉêÇë] ¹ú×Ô¿ÆÃæÉÏ»ù½ð×ÖÌå +6 iwuli 2026-03-12 7/350 2026-03-16 21:18 by sculhf
[¿¼ÑÐ] 0703Ò»Ö¾Ô¸211 285·ÖÇóµ÷¼Á +5 ly3471z 2026-03-13 5/250 2026-03-16 16:16 by ŶŶ123
[¿¼ÑÐ] 070303Ò»Ö¾Ô¸Î÷±±´óѧѧ˶310ÕÒµ÷¼Á +5 dÈçÔ¸Éϰ¶ 2026-03-12 8/400 2026-03-16 15:19 by peike
[¿¼ÑÐ] 0703 ÎïÀí»¯Ñ§µ÷¼Á +3 ÎÒ¿ÉÒÔÉϰ¶µÄ¶Ô 2026-03-13 5/250 2026-03-16 10:50 by ÎÒ¿ÉÒÔÉϰ¶µÄ¶ÔÂ
[¿¼ÑÐ] 085601²ÄÁϹ¤³Ì315·ÖÇóµ÷¼Á +3 yang_0104 2026-03-15 3/150 2026-03-15 10:58 by peike
[¿¼ÑÐ] 297Ò»Ö¾Ô¸ÉϽ»085600Çóµ÷¼Á +5 Ö¸¼â°ËǧÀï 2026-03-14 5/250 2026-03-14 17:26 by a²»Ò×
[¿¼ÑÐ] 331Çóµ÷¼Á£¨0703Óлú»¯Ñ§ +5 ZY-05 2026-03-13 6/300 2026-03-14 10:51 by Jy?
[¿¼ÑÐ] ÕÐÊÕ0805£¨²ÄÁÏ£©µ÷¼Á +3 18595523086 2026-03-13 3/150 2026-03-14 00:33 by 123%¡¢
[¿¼ÑÐ] 0856²ÄÁÏÓ뻯¹¤301Çóµ÷¼Á +5 ÞÈÊø¹â 2026-03-13 5/250 2026-03-13 22:00 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄϽ»´ó£¬²ÄÁÏר˶317Çóµ÷¼Á +5 lx8568 2026-03-11 5/250 2026-03-13 21:43 by peike
[¿¼ÑÐ] Çóµ÷¼Á +3 ³ÌÓ꺼 2026-03-12 3/150 2026-03-13 15:06 by JourneyLucky
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤ 309·ÖÇëÇóµ÷¼Á +7 dtdxzxx 2026-03-12 8/400 2026-03-13 14:43 by jxchenghu
[¿¼ÑÐ] 290Çóµ÷¼Á +3 ADT 2026-03-13 3/150 2026-03-13 10:19 by peike
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û